Safety and efficacy of two-port thoracoscopic aortic valve replacement

Journal of Cardiothoracic Surgery

Research

Jian Zhuang¹  Yanjun Liu¹  Jimei Chen¹  Huiming Guo¹  Huanlei Huang¹  Jian Liu¹  Peijian Wei²  Tong Tan³ 

[1] Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China;Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China;Department of Structure Heart Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China;Shantou University Medical College, Shantou, China;Department of Cardiovascular Surgery, Guangdong Cardiovascular Institute, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China;Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangzhou, China;

关键词: Minimally invasive;    Endoscopic surgery;    Totally thoracoscopic aortic valve replacement;    Aortic valve replacement;    Acute kidney injury;   

DOI  :  10.1186/s13019-022-02086-0

 received in 2022-03-25, accepted in 2022-12-11,  发布年份 2022

来源: Springer

【 摘 要 】

BackgroundPure aortic valve disease is common and has been treated with sternotomy aortic valve replacement for decades. Minimally invasive cardiac surgery has been widely used in atrioventricular valve lesions, but totally thoracoscopic aortic valve replacement has rarely been reported.MethodThe profiles of 9 patients who were diagnosed with severe aortic valve diseases and treated with two-port thoracoscopic aortic valve replacement between February 2021 and February 2022 were retrospectively reviewed. The clinical data, including baseline characteristics, operative data, postoperative complications, and short-term outcomes, were reported.ResultsAll nine patients successfully underwent two-port thoracoscopic aortic valve replacement, with a cardiopulmonary bypass time of 137.56 ± 27.99 min and an aortic cross-clamp time of 95.33 ± 17.96 min. Seven (77.78%) patients underwent mechanical valve replacement, and two (22.22%) patients underwent bioprosthetic valve replacement. Two (22.22%) patients underwent a concomitant aortic root enlargement procedure. There were no intraoperative or postoperative deaths. The incidence of procedural complications was 0%, while the results of ventilation time, intensive care unit stay length, blood transfusion, chest tube drainage, and kidney function were satisfactory.ConclusionTwo-port thoracoscopic aortic valve replacement is a safe and effective surgical treatment option for carefully selected patients with pure aortic valve diseases.

【 授权许可】

CC BY   
© The Author(s) 2023

【 图 表 】

Fig. 2

41116_2022_35_Article_IEq116.gif